Why might stopping drug use become harder in one place than another? A smell, object or companion associated with past use may draw attention and make something the person had decided to avoid feel urgent. The iRISA model examines how that importance and difficulty stopping a response contribute to addiction.

01

The same decision in two places

A person who wants to stop using a drug plans their evening at home. Later they pass a place associated with past use and notice a familiar smell, a companion or an object. The decision has not changed in words, but the setting has changed what draws attention and what feels urgent. That difference is central to the iRISA model reviewed by Ahmet Ceceli, Rita Goldstein and colleagues. Its name stands for impaired response inhibition and salience attribution. In ordinary language, it asks how a drug-related cue can become unusually important while it becomes harder to pause or redirect a response.

The opening scene is an illustration, not a diagnosis of a particular person. Addiction is not explained by one moment, one brain region or a single failure of will. Drug effects, repeated learning, withdrawal, stress, social conditions and access to support all matter. The model focuses on one interaction that might help explain why the same person can behave differently in different contexts. Treating that variation seriously can improve both the questions researchers ask and the way others respond to someone who struggles.

The review revisits a model introduced in 2001 using two decades of neuroimaging and behavioral work. Its authors are especially concerned with testing the interaction, not merely showing that a person reacts strongly to a picture of a drug or scores differently on a generic self-control task. The difficult question is what happens to a cognitive function when the drug-related cue is present.

02

Why a cue can outweigh alternatives

Salience is the importance that a signal acquires for attention and action. A drug-related cue can be a visible object, a place, a person or a state of the body learned through past experience. If it repeatedly predicts use or relief, it may draw attention more forcefully than an alternative reward. This does not mean everyone with an addiction reacts to every cue, or that the cue physically forces a choice. It means an ordinary environment can carry a learned value that changes the balance of competing possibilities.

Researchers study cue reactivity with images, words or other reminders while measuring reported craving, behavior and brain activity. The prefrontal cortex is of particular interest to the review, including orbitofrontal, dorsolateral, anterior cingulate and inferior frontal regions. These labels do not identify four simple buttons. The regions participate in networks involved in value, attention and control. A scan can show that activity differs between conditions or groups; interpreting that difference requires knowing the task and the person's recent use and current state.

A cue may also be meaningful because of a person's circumstances. Seeing an alcohol advertisement after an exhausting day is different from seeing it in a calm setting with support. A laboratory image approximates only part of this context. The review calls for greater ecological validity: ways to study how cues matter in the changing environments where decisions actually occur. Without this, a robust signal in a scanner might tell us less than we hope about daily life.

03

Stopping a response is a task, not a character trait

Response inhibition is the ability to withhold or change an action that was about to occur. A common experiment asks someone to respond quickly to many signals but not to one particular signal. Mistakes can reveal how hard the stop rule is under specific conditions. Yet a score from that task should not be translated into 'this person has no self-control.' Performance depends on attention, fatigue, practice, the importance of the cue and how the task is set up. Control is a function people exercise in contexts, not an amount of virtue they possess.

The iRISA account proposes that a drug-related context can make stopping more difficult at the same time as it makes drug cues more compelling. This is why a test conducted only with neutral material gives an incomplete picture. Someone might perform well on neutral trials and struggle when the target is associated with use. Conversely, a difference found with drug cues should not be taken as a global inability to decide or think. The interaction between cue and cognitive demand is the object of explanation.

The authors also examine awareness of choice. People do not always accurately describe the influences on their behavior. That limitation is not unique to addiction, but it can matter when cues and craving are strong. Impaired insight should be measured carefully, not presumed whenever someone disagrees with a clinician. A person's account, task performance and physiological measures each capture different parts of the experience. Bringing them together requires respect for both the person and the limits of each instrument.

04

The key test is the interaction

Imagine two tasks: one asks participants to ignore a neutral picture, the other to ignore a drug-related picture. A useful test of iRISA compares how the picture changes stopping or another cognitive function and whether this change differs by relevant features such as use severity or craving. Simply finding a response to drug pictures in the brain is not enough. Nor is finding poorer inhibition on a separate task. The model predicts that cue and cognitive function affect one another under particular conditions.

That design is harder than it sounds. Drug-related images may differ from neutral images in familiarity, emotional intensity or visual complexity. Participants vary in recent use, treatment, medication and withdrawal. A group average can hide people for whom a cue matters little and others for whom it matters greatly. The authors argue for careful measurement of these differences and for outcomes that can be interpreted clinically. A pattern in one task should not be generalized to every substance or every stage of recovery.

The prefrontal findings become useful when they explain a behavioral difference, not when a region is announced as 'broken.' Brain activity can increase because a task is harder, because a person is compensating or because a different strategy is used. The same observation can fit more than one story. Combining tasks, timing, behavior and follow-up gives a more demanding test. It also opens the possibility of discovering when the model needs revision rather than merely collecting examples that resemble it.

05

Recovery belongs in the picture

A model of addiction that describes only difficulty misses a crucial question: what changes when people receive support or stop using? The review discusses evidence that cognitive functions and their neural correlates can improve with abstinence and treatment. It considers behavioral approaches, medication and emerging forms of brain stimulation. These are not interchangeable cures, and a change on a scan is not automatically a meaningful improvement in everyday life. The important point is that the brain and behavior are not frozen at a diagnosis.

Recovery may involve a different response to cues, improved ability to redirect attention, changes in craving or simply a more supportive environment. These mechanisms can overlap. A person may make progress before a particular laboratory measure moves, or a measure may move without a durable benefit. For a proposed biomarker to be useful, it must reliably track an outcome that matters and do so across relevant people and settings. The authors call for this validation rather than treating every striking neural difference as a marker ready for practice.

This account also cautions against blame. If cues and cognitive demands interact, advice to 'just stop' ignores conditions that can be changed. Reducing exposure to high-risk situations, arranging support and testing treatments are practical responses to a context-sensitive problem. This does not remove a person's agency; it helps create circumstances in which that agency can be exercised. The research question becomes how to make recovery more possible, not how to sort people into strong and weak.

06

New tools need questions worth answering

The authors end by looking beyond familiar scanner tasks. Computational models can express how a person learns the value of a cue or changes a choice. Analysis of spontaneous speech may reveal aspects of attention and experience that a simple button press misses. Mobile or more naturalistic designs might capture context as it changes through a day. None of these innovations is valuable merely because it is technologically impressive. It must improve measurement, prediction or care while protecting the meaning and limitations of the data.

A strong future study would ask a specific question: Does a cue-related change in inhibitory control predict difficulties in a person's ordinary environment, and does that measure respond when effective help changes their situation? It would compare alternatives, follow people over time and test whether the result extends beyond the sample in which it was found. It would also avoid assuming that a correlation between a brain signal and a symptom identifies a single cause.

Return to the person who passed the familiar place. Their struggle cannot be reduced to one cue, and their plan at home was not insincere. The review explains why context may change the mental work needed to carry out that plan. It also shows why recovery and individual variation belong in the same account as risk. The useful takeaway is a question about conditions: when does a signal capture attention, what ability is affected, and what support helps the person choose differently?

What to keep

  1. Drug cues can dominate salience.
  2. Inhibition depends on context.
  3. Recovery is an essential part of the evidence.
?

The nuance

What this story does not let us claim

Brain differences are heterogeneous and should not be interpreted as permanent damage in every individual.

Go deeper: concepts and optional reading practice

Reversible cards

Test the concept

1 / 1

Topic assessment

Check whether you can explain the idea, not merely recognize it.

Every answer is grounded in the explanation above. Some questions introduce new cases to test whether you can apply and analyze the ideas, not merely recall them.

7 questions4 options per questionOne correct answer
01Which statement best captures the review’s central thesis?
02Which is the most appropriate operational definition of “Salience attribution”?
03Which case correctly applies the central concept?
04If two studies obtain different results, which interpretation best preserves the logic of this guide?
05Which complementary conclusion belongs to the paper’s core argument?
06Which formulation best distinguishes “Salience attribution” from a superficial label?
07Which limit should accompany any application of the paper to a new case?
Answer all seven questions.

Source & scope

The Impaired Response Inhibition and Salience Attribution Model of Drug Addiction: Recent Neuroimaging Evidence and Future Directions. Ahmet O. Ceceli, Yuefeng Huang, Greg Kronberg, Natalie McClain, Sarah G. King, Eduardo R. Butelman, Nelly Alia-Klein & Rita Z. Goldstein. Annual Review of Psychology, vol. 77 (2026).

This editorial guide is an independent explanation. Consult the original publication for the studies, references and full context.

Open the original review ↗